Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Moertel, Christopher
- Contributor
-
Xi, Junzhe
Olin, Michael R.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P169
- URN
-
urn:nbn:de:1111-2016072654311
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moertel, Christopher
- Xi, Junzhe
- Olin, Michael R.
- SpringerLink (Online service)
Other Objects (12)
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
GPR65 contributes to constructing immunosuppressive microenvironment in glioma
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models
Intra‐operative Definition of Glioma Infiltrative Margins by Visualizing Immunosuppressive Tumor‐Associated Macrophages
Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
GPR65 contributes to constructing immunosuppressive microenvironment in glioma
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models
Intra‐operative Definition of Glioma Infiltrative Margins by Visualizing Immunosuppressive Tumor‐Associated Macrophages
Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
GPR65 contributes to constructing immunosuppressive microenvironment in glioma
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models
Intra‐operative Definition of Glioma Infiltrative Margins by Visualizing Immunosuppressive Tumor‐Associated Macrophages